Dr. Matthias Staufenbiel

Dr. Matthias Staufenbiel, a neuroscientist, is currently a Research Consultant at the Hertie Institute for Clinical Brain Research, University of Tübingen.

Between 1988 to 2012, Dr Staufenbiel held leading positions in Novartis and Sandoz, focusing on neurodegeneration, especially Alzheimer's disease in preclinical neuroscience research.

Before that, he had an independent research position at the Max - Planck - Institute for Cell Biology in Ladenburg and a postdoc in cell biology at the California Institute of Technology.

He is co - author of more than 200 scientific publications and was recognized as an “Outstanding Scientist” at Novartis for his significant contributions to Alzheimer's disease drug development.

Matthias studied biology at the University of Konstanz. He received his Ph.D. from the Max - Planck - Institute for Biophysical Chemistry in Göttingen and the University of Ulm.